|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-20 | BioRegenx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-15 | BioRegenx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 6.79M 5.87M 5.49M 5.03M 9.47M 646M 9.62M 64.36M 25.26M 324M 25.5M 24.94M 1.07B | P/E 2024 |
-0.37x | P/E 2025 | -8.02x |
|---|---|---|---|---|---|
| Enterprise Value | 8.94M 7.73M 7.22M 6.62M 12.46M 850M 12.65M 84.69M 33.24M 426M 33.56M 32.82M 1.41B | EV / Sales 2024 |
4.58x | EV / Sales 2025 | 7.85x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
William Resides
CEO | Chief Executive Officer | 57 | 07/03/2024 |
Gary Hennerberg
SEC | Corporate Secretary | 69 | 07/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Powers
BRD | Director/Board Member | 71 | 31/12/2011 |
William Resides
BRD | Director/Board Member | 57 | 07/03/2024 |
Suzanne Bird
BRD | Director/Board Member | 61 | 07/03/2024 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.34M 2.02M 1.89M 1.73M 3.26M 223M 3.31M 22.18M 8.7M 112M 8.79M 8.6M 369M | 1.85M 1.6M 1.5M 1.37M 2.58M 176M 2.63M 17.58M 6.9M 88.46M 6.96M 6.81M 292M |
| Net income | -23.05M -19.94M -18.62M -17.08M -32.13M -2.19B -32.64M -218M -85.76M -1.1B -86.57M -84.68M -3.64B | -1.54M -1.34M -1.25M -1.14M -2.15M -147M -2.19M -14.63M -5.74M -73.63M -5.8M -5.67M -243M |
| Net Debt | 2.11M 1.82M 1.7M 1.56M 2.94M 200M 2.98M 19.96M 7.83M 100M 7.91M 7.73M 332M | 2.15M 1.86M 1.73M 1.59M 2.99M 204M 3.04M 20.33M 7.98M 102M 8.06M 7.88M 338M |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















